Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.02%
median of 823 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
Silexion Therapeutics Ltd.
Market Cap
$108771.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$96046.00
Net Profit Margin
N/A
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$72318.00
Net Profit Margin
-22521.52%
TTM Avg
-14229.41%
3Y Avg
-9670.52%
5Y Avg
-6447.01%
Market Cap
$61819.00
Net Profit Margin
-17690.19%
TTM Avg
-9089.88%
3Y Avg
-5029.73%
5Y Avg
-25219.12%
Market Cap
$30664.00
Net Profit Margin
-44.25%
TTM Avg
-77.97%
3Y Avg
-46.13%
5Y Avg
-41.70%
Market Cap
$6197.00
Net Profit Margin
N/A
TTM Avg
99.68%
3Y Avg
52.40%
5Y Avg
41.92%
Market Cap
$243502.00
Net Profit Margin
-1422.78%
TTM Avg
-951.97%
3Y Avg
-568.57%
5Y Avg
-575.76%
Market Cap
$381125.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-352.76%
5Y Avg
-376.69%
Market Cap
$481786.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Silexion Therapeutics Ltd. (SLXN) | $108771.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Psyence Biomedical Ltd. (PBM)vs › | $96046.00 | N/A | 0.00% | 0.00% | 0.00% |
| PRF Technologies Ltd. (PRFX)vs › | $72318.00 | -22521.52% | -14229.41% | -9670.52% | -6447.01% |
| Akanda Corp. (AKAN)vs › | $61819.00 | -17690.19% | -9089.88% | -5029.73% | -25219.12% |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $30664.00 | -44.25% | -77.97% | -46.13% | -41.70% |
| NewGenIvf Group Limited (NIVF)vs › | $6197.00 | N/A | 99.68% | 52.40% | 41.92% |
| SciSparc Ltd. (SPRC)vs › | $243502.00 | -1422.78% | -951.97% | -568.57% | -575.76% |
| Niki BioSolutions, Inc. (NIKI)vs › | $381125.00 | 0.00% | 0.00% | -352.76% | -376.69% |
| XORTX Therapeutics Inc. (XRTX)vs › | $481786.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| HCW Biologics Inc. (HCWB)vs › | $556226.00 | -73.22% | -7923.42% | -4237.01% | -2848.17% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
